medicine

Grown Rogue Talks Growth Strategy in Exclusive Interview

Multi-state operators, or MSOs, have become increasingly common across the United States given their economies of scale. With the industry’s relatively easy access to capital, many of these MSOs have bought up assets at all costs to rapidly build a footprint. Investors may want to avoid some of these companies and seek out those that […]

FSD Pharma CEO Lays Out Roadmap in Exclusive Interview with CFN Media

FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) is a licensed producer focused on building out a 3.9 million sq. ft. indoor hydroponic facility near Toronto capable of producing 400,000 kilograms of dried cannabis per year. With a newly acquired sales license and 25,000 sq. ft. already in production, the company is on the cusp of […]

Northern Lights Organics Advances CBD Hemp Operations

Organic Hemp Farm Provides Detailed Update on Certified Organic CBD Results as Canadian Market Prepares to Expand VANCOUVER, BC / ACCESSWIRE / May 9, 2019 / Weekend Unlimited Inc. (“Weekend” or the “Company”) (CSE: POT – FSE: 0OS1 – OTCQB: WKULF) is pleased to provide an update on the advancement toward full scale production on its […]

Halo Labs Improves Transparency with Move to OTCQX

Many Canadian cannabis companies trade on the OTC Markets rather than a national exchange due to restrictive U.S. cannabis regulations and higher costs. While many U.S. investors have access to OTC-listed securities, there is a wide range of transparency levels that can impact investment decisions and liquidity. The OTCQX® is the highest tier of the […]

FSD Pharma Investments Pay Off Amid ‘Robust Expansion’ at Ontario Facility

FSD Pharma’s strategic investment portfolio valued at $18 million after a market-to-market unrealized gain of $10 million. Management remains tightly focused on ’robust expansion’ plan at its Cobourg, Ontario facility under the leadership of Dr. Sara May. Balance sheet includes $22 million in cash, as of December 31, 2018, with total net assets in excess […]

FSD Pharma Doubles Down on Endocannabinoid-based Pain Management

Chronic pain is a widespread condition affecting about one-third of the American population and billions of other people around the world. Despite their widely known dangers, opioids quickly became one of the most prescribed and profitable classes of drugs in the world. The ensuing opioid crisis has made overdoses a leading cause of non-disease deaths […]

Who Were the Winners at this Year’s O’Cannabiz Awards?

The O’Cannabiz Conference & Expo is happening at The International Centre in Toronto this week. With keynote speakers like Montel Williams and Ricki Lake, along with more than 275 exhibitors, the conference has considered to be one of the most influential cannabis conferences in the world covering a wide range of topics, including policy, marketing, […]

Why Cannabis Genetics Matter & How to Invest in Innovations

Cannabis cultivators and budtenders love to talk about genetics. While everyone has an opinion on the effects of specific strains, recent research suggests that the effects of cannabis aren’t necessarily consistent with strains, and the generally accepted classifications of indiva, sativa and hybrid varieties may be flawed. Very few companies are investing in truly understanding […]

MediPharm Labs Executing on International Cannabis Extracts Strategy

Canadian companies have a bit of a head start on those from other countries where the legal cannabis framework is not as comprehensive or advanced. In many ways, countries around the globe look to Canada as a model. In fact, Australia has basically adopted Canadian medical regulations and is a few years behind Canada in […]

Lexaria Bioscience Announces Beverage License Agreement with California-Based Cannabis Company

KELOWNA, BC / ACCESSWIRE / April 24, 2019 / Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the ”Company” or ”Lexaria”), a drug delivery platform innovator, announces that it has entered a definitive 5-year agreement, via its subsidiary Lexaria CanPharm ULC, to provide Lexaria’s patented DehydraTECHTM technology to a private California-based cannabis company for its utilization in certain […]

Halo Expands Branded Products & Launches Hemp CBD Products

The cannabis industry is projected to reach $146.4 billion by 2025, according to Grand View Research, driven by the legalization of recreational cannabis across a growing number of states and countries. While there are many different opportunities in the space, there are only a handful of companies that have proven their ability to generate significant […]

FSD Pharma Secures Sales License for Massive Production Facility

Canada’s cannabis industry has experienced tremendous growth over the past several years, following the legalization of medical and adult-use cannabis. In addition to growing domestic demand, the country’s move to federally regulate cannabis has opened the door for its licensed producers to export products around the world. These dynamics have made licensed producers a valuable […]

The Spotlight Shines on CFN Media’s Clients at The O’Cannabiz Awards

The O’Cannabiz Conference and Expo is coming to Toronto on April 25, bringing together thousands of cannabis experts and brands. Ricki Lake, Montel Williams, Jacqui Childs, Henry Rollins and other famous personalities will be featured speakers at the High Canada Magazine #1 Cannabis Event in Canada, while investors can learn about topics ranging from policy […]

CFN Media to Film Exclusive Interviews at Benzinga Cannabis Capital 2019

The Benzinga Cannabis Capital Conference returns to Toronto this week, bringing together cannabis entrepreneurs and investors from across North America. CFN Media will be at the conference filming exclusive interviews with leading startups, public companies and investment firms involved in the space to deliver cutting-edge insights. We will also be talking to familiar faces like […]

Why Women, the Fastest Growing Consumers of Cannabis, are the Demographic to Watch

Although women control around $30 trillion in annual spending, the majority of companies often ignore this powerhouse of a demographic. Millennial women in particular tend to enjoy an above-average household income, and have been estimated to represent a $170 billion dollar market. Despite being a newer industry with a keen ability to identify exciting new […]

Israel Decriminalizes Adult Use Cannabis in Another Step Toward Legalization

Israel decriminalized adult use cannabis on April 1 — just days before the Jewish state’s April 9 election. The new law makes it legal for Israeli citizens to possess homegrown marijuana plants, while carrying small amounts of cannabis in public will only result in a fine rather than an arrest. The move follows similar legislation […]

FSD Pharma Explores Insurance Coverage for Medical Cannabis in Canada

Cannabis investors have been focused largely on the recreational market with the legalization of adult-use cannabis last year, but a growing body of research suggests that medical cannabis remains a compelling long-term opportunity. The biggest question mark has been surrounding insurance coverage, which could prove to be a game-changer by making medical cannabis a lot […]

Harvest One Ensures Cannabis Supply with Greenbelt Acquisition

Vertical integration has become kind of a buzzword in the cannabis industry over the last few years. Many companies claim it as a goal, with the intent of controlling the whole supply chain for their products from seed-to-sale. Getting to that level of control can prove difficult, however, as the resources, equipment, and expertise required […]

American Cannabis Market Fueled By Positive Legislation

Cannabis may be illegal on a federal level across the United States, but that hasn’t stopped a multi-billion dollar industry from emerging on the state level. While some investors have avoided the country’s cannabis market due to the federal risk, new cannabis legislation in the House and Senate could dramatically reshape the industry’s risk profile. […]

FSD Pharma Appoints Charles Pollack Jr. MD, FACEP as Chairman of the Scientific Advisory Board

TORONTO FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), announced today the appointment of Charles V. Pollack, Jr., M.A., M.D., FACEP, FAAEM, FAHA, FACC, FESC, FCPP, as Chairman of its Scientific Advisory Board (“SAB”). In this capacity Dr. Pollack will serve as a strategic guide and resource to the Company […]

Aleafia Health Appoints Lead Independent Director

TORONTO, April 04, 2019 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has appointed Loreto Grimaldi as the Lead Independent Director of the Company’s Board of Directors. The role will rotate among independent directors every six months, as determined periodically by a majority of the Company’s […]

ISRACANN Biosciences: Invest in Israel’s First Cannabis Pure-Play Public Offering

North America may be capturing most of the headlines when it comes to the cannabis industry, but other global cannabis frontier markets could offer greater growth potential. Israel is already well-known as the cannabis research capital of the world. Similarly, it also has a nascent domestic cannabis industry with one of the highest ratios of […]

Cannabis Traceability: Problems & Solutions

The global cannabis industry is projected to reach $146.4 billion by 2025, according to Grand View Research, representing a 34.6 percent compound annual growth rate over the time period. Despite these rapid growth rates, the industry has faced several high profile traceability issues in Washington, Nevada, Michigan, Oregon, and Pennsylvania, including diversion into the black […]

FSD Pharma Promotes New Leadership & Advances Projects

Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of recreational cannabis last year and the upcoming legalization of oils, concentrates and edibles. Investors have many opportunities in the space, but few companies offer both a massive production footprint and strategic investments in new […]

Yield Growth Builds Impressive Distribution Network

The cannabis industry is maturing and consumers have access to an increasingly large number of brands. As competition between brands heats up, investors have focused on distribution when assessing future revenue potential. Cannabis companies with innovative products and established distribution channels will be best positioned to grow their revenue through both more point-of-sale opportunities and […]

Harvest One Executing on Brands and Distribution Strategy

The nature of the compelling stories in the cannabis industry has changed over the last few years. Remember when a late-stage ACMPR applicant was all the rage? Then it was production expansion and funded capacity. Now, all of that potential is turning to the reality of any market – who can sell product and generate […]

Supreme Cannabis Scales Up Production & Into Higher Margin Product Lines

Canada’s cannabis industry continues to experience a supply shortage, according to Cowen & Co., which found that nearly half of all items remained out of stock on five provincial e-commerce websites. With the legalization of edibles expected in October, these supply shortages could increase as the industry broadens its customer base. These dynamics have created […]

MediPharm Labs Sets Date to Release Fourth Quarter and Full Year 2018 Financial Results

TORONTO, March 27, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, will release its fourth quarter and full year financial results ended December 31, 2018 before markets open on Wednesday, April 3, 2019. […]

BLOCKStrain Technology Announces Third-Quarter Product Update

Canada NewsWire VANCOUVER, March 27, 2019 Significant Enhancements Drive Usability and Performance VANCOUVER, March 27, 2019 /CNW/ – BLOCKStrain Technology Corp. (TSX:V: DNAX.V) (OTC: BKKSF) (“BLOCKStrain” or the “Company”), creator of the first blockchain-secured, fully-integrated IP tracking platform for the cannabis industry, announced the implementation of several significant product updates to its core technology, aimed at driving […]

CFN Media Interviews High Hampton’s CEO to Discuss 2019 Catalysts

  California’s cannabis industry could reach $5.1 billion in 2019, according to Arcview Market Research and BDS Analytics, driving much of the growth in the wider U.S. market. With nearly 40 million residents and more than a million medical marijuana patients, the state accounts for nearly one third of the North American cannabis market. These […]